Puration Inc Confirms Cannabis Pharmaceutical Partnership Developments with Kali and Nouveau
DALLAS, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today confirmed the developing joint venture agreement with Kali, Inc. (USOTC: KALY) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to develop cannabis pharmaceutical products. Puration further confirms plans to host representatives from Kali and Nouvea in Dallas next week to finalize JV details.
Kali, Inc has schedule an online presentation scheduled Friday, November 2nd, 2018 to detail the strategy behind the recently announced JV plans.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.